Investigating cognitive decline and dementia in older patients with kidney disease

Cognitive Decline and Incident Dementia in Older Patients with Secondary Hyperparathyroidism

NIH-funded research Johns Hopkins University · NIH-11015789

This study is looking at how high levels of a hormone related to kidney disease might affect thinking and memory in older adults with severe kidney problems, hoping to find ways to help improve their brain health and overall quality of life.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11015789 on NIH RePORTER

What this research studies

This research focuses on older adults with end-stage renal disease (ESRD) to understand how secondary hyperparathyroidism (SHPT) may contribute to cognitive decline and the development of dementia. The study will analyze the relationship between high levels of parathyroid hormone and cognitive impairment, using biomarkers to assess their impact on brain function. By identifying modifiable risk factors, the research aims to improve the quality of life for patients suffering from cognitive issues related to kidney disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults aged 55 and above who are living with end-stage renal disease.

Not a fit: Patients who are younger than 55 or do not have end-stage renal disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing cognitive decline and dementia in older patients with kidney disease.

How similar studies have performed: Previous research has indicated a correlation between parathyroid hormone levels and cognitive impairment, suggesting that this approach may yield valuable insights.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.